- Home
- TBPH vs DC Comparison
TBPH vs DC Comparison
Compare TBPH & DC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBPH | DC |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | 41 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.9M | 783.8M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | TBPH | DC |
|---|---|---|
| Price | $16.45 | $5.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $18.40 | $9.48 |
| AVG Volume (30 Days) | 559.9K | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 279.13 | N/A |
| EPS | ★ 2.06 | N/A |
| Revenue | ★ $15,386,000.00 | N/A |
| Revenue This Year | $1.04 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.82 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.09 | $2.53 |
| 52 Week High | $21.03 | $7.25 |
Technical Indicators
Market Signals| Indicator | TBPH | DC |
|---|---|---|
| Relative Strength Index (RSI) | 58.98 | 47.26 |
| Support Level | $13.41 | $4.38 |
| Resistance Level | $19.04 | $5.51 |
| Average True Range (ATR) | 0.53 | 0.30 |
| MACD | 0.37 | 0.09 |
| Stochastic Oscillator | 99.04 | 77.83 |
Price Performance
Historical ComparisonAbout TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
About DC Dakota Gold Corp.
Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 48 thousand acres surrounding the historic Homestake Mine. Company project includes Richmond Hill Project.